This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Kazuhide Furukawa: Innovating Choleretics for Medical Use
Introduction
Kazuhide Furukawa is a prominent inventor based in Tosu, Japan. With a sharp focus on medical innovations, he has made significant strides in the field of pharmaceuticals. His work primarily revolves around developing new choleretic agents that showcase enhanced efficacy and safety.
Latest Patents
Furukawa holds a noteworthy patent related to choleretics. His invention features one or more limonene derivatives, specifically selected from p-mentha-1,8-diene, p-menth-1-ene-8,9-diol, 9-acetoxy-p-menth-1-en-8-ol, and 9-propionyloxy-p-menth-1-en-8-ol. This innovative formulation displays remarkably high choleretic activity when compared to conventional choleretics, ensuring a high safety profile for medical use.
Career Highlights
Kazuhide Furukawa is associated with Hisamitsu Pharmaceutical Company, Inc., where he contributes his expertise in pharmaceutical research and development. His dedication to advancing medical therapies underscores his commitment to improving patient outcomes through innovative solutions.
Collaborations
During his career, Furukawa has collaborated with notable colleagues, including Kanji Noda and Ryuhei Kodama. Together, they have worked on various projects aimed at enhancing drug development and addressing medical needs.
Conclusion
Kazuhide Furukawa exemplifies the spirit of innovation in the pharmaceutical industry. Through his patented work on choleretics and collaborations with talented professionals, he continues to push the boundaries of medical science, contributing to the development of safer and more effective treatments. His achievements reflect a significant impact on healthcare, showcasing the importance of innovation in improving medical therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile